UPXI Key Statistics, Chart & Performance
The current stock price of UPXI is 2.7134 USD. In the past month the price decreased by -19.64%. In the past year, price decreased by -51.81%.
UPXI Latest News, Press Relases and Analysis
UPXI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 62.55 | 37.87B | ||
| KVUE | KENVUE INC | 15.67 | 32.12B | ||
| ELF | ELF BEAUTY INC | 25.5 | 4.68B | ||
| BRBR | BELLRING BRANDS INC | 14.04 | 3.65B | ||
| COTY | COTY INC-CL A | 17.97 | 2.99B | ||
| IPAR | INTERPARFUMS INC | 15.81 | 2.66B | ||
| OLPX | OLAPLEX HOLDINGS INC | 15.56 | 831.05M | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.5 | 766.59M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.04 | 473.36M | ||
| NATR | NATURES SUNSHINE PRODS INC | 22.81 | 375.20M | ||
| USNA | USANA HEALTH SCIENCES INC | 10.14 | 363.41M | ||
| HNST | HONEST CO INC/THE | 44.33 | 297.36M |
Related stock screener links
About UPXI
Company Profile
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
Company Info
UPEXI INC
3030 Rocky Point Drive, Suite 420
Tampa FLORIDA US
Employees: 59
Phone: 17013535425
UPEXI INC / UPXI FAQ
Can you describe the business of UPEXI INC?
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
What is the current price of UPXI stock?
The current stock price of UPXI is 2.7134 USD. The price increased by 2.01% in the last trading session.
What is the dividend status of UPEXI INC?
UPXI does not pay a dividend.
What is the ChartMill rating of UPEXI INC stock?
UPXI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is UPEXI INC worth?
UPEXI INC (UPXI) has a market capitalization of 171.51M USD. This makes UPXI a Micro Cap stock.
Who owns UPEXI INC?
You can find the ownership structure of UPEXI INC (UPXI) on the Ownership tab.
UPXI Technical Analysis
UPXI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to UPXI. Both the profitability and the financial health of UPXI get a neutral evaluation. Nothing too spectacular is happening here.
UPXI Financial Highlights
Over the last trailing twelve months UPXI reported a non-GAAP Earnings per Share(EPS) of -3.6. The EPS increased by 82.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 264.27% | ||
| ROA | 13.03% | ||
| ROE | 25.94% | ||
| Debt/Equity | 0.92 |
UPXI Forecast & Estimates
8 analysts have analysed UPXI and the average price target is 15.81 USD. This implies a price increase of 482.66% is expected in the next year compared to the current price of 2.7134.
For the next year, analysts expect an EPS growth of 103.26% and a revenue growth 147.95% for UPXI